| Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common Immunodeficiency (NCT05481554) | Assistance Publique - Hôpitaux de Paris | 2022-07-01 |
| COVID-19 Vaccine Responses in PIDD Subjects (NCT05321407) | Duke University | 2021-09-30 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity (NCT04339777) | National Cancer Institute (NCI) | 2020-09-22 |
| Lymphocyte Immunophenotyping in Common Variable Immunodeficiency (NCT01196702) | Barts & The London NHS Trust | 2020-09-01 |
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation (NCT03663933) | National Cancer Institute (NCI) | 2018-09-04 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation (NCT03513328) | University of Florida | 2018-06-15 |
| The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease (NCT03211689) | Stockton University | 2017-06-27 |
| Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide (NCT03188419) | National Cancer Institute (NCI) | 2017-06-14 |
| Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies (NCT02579967) | National Cancer Institute (NCI) | 2015-11-19 |
| Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (NCT01884311) | Bio Products Laboratory | 2015-08-20 |
| Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases (NCT01963143) | Bio Products Laboratory | 2014-02-01 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NCT01652092) | Masonic Cancer Center, University of Minnesota | 2012-09-04 |
| A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency (NCT01289847) | Bio Products Laboratory | 2011-03-01 |
| Human IgGs and Endothelial Function in Vivo in Humans (NCT03534479) | Federico II University | 2010-04-01 |
| Natural History of Bronchiectasis (NCT00943514) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-08-01 |
| "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency (NCT01489618) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-06-01 |
| Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (NCT00542997) | CSL Behring | 2007-09-01 |
| Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency (NCT00520494) | CSL Behring | 2007-03-01 |
| STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency (NCT00263237) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-02 |
| Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) (NCT00322556) | CSL Behring | 2005-11-01 |
| Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) (NCT00168025) | CSL Behring | 2004-09-01 |
| Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients (NCT00220766) | Grifols Therapeutics LLC | 2002-08-01 |
| Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin (NCT00661401) | Federal University of São Paulo | 2002-01-01 |
| Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms (NCT00015431) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-16 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies (NCT00006054) | Fairview University Medical Center | 2000-03-01 |